Selecting the Best Heart Failure Treatment and Surgery Centres in India for Australian Patients

Author:- Dr. Dheeraj Bojwani Date Created:- 21-08-2026

Advanced heart failure care is a genuinely specialised field, and this guide is written for patients whose Australian cardiology team has confirmed they need surgical or device-based treatment beyond medication alone. In 24 years of guiding international patients into Indian hospitals, this gap is worth understanding clearly before anything else, because it's not a reflection of who might benefit from advanced treatment; it's the genuine constraint of donor organ availability. For most patients facing advanced heart failure, transplant was never going to be the pathway, which is precisely why the LVAD landscape matters so much.

Healing Journeys of Australian Patients

Australian Patients Share Their Experience

Key Takeaways

• The guide focuses on Australian patients whose cardiology team has confirmed that they may need advanced heart failure treatment beyond medication alone. It explains that donor-organ availability creates a major limitation for heart transplantation and highlights LVAD as an increasingly important option for patients who may not be eligible for transplant.
• A major point is the importance of making an honest LVAD-versus-transplant decision based on the patient's individual clinical profile. The guide places this criterion at the highest weight and recommends asking the treating team why one pathway is being recommended and what alternatives have been considered.
• The guide gives 55 points to the surgical team and 45 points to the hospital. Team assessment includes experience in advanced heart failure surgery, LVAD volume, device selection, personal involvement and procedure-specific complication and survival data.
• Hospital assessment focuses on a dedicated cardiac surgical ICU, multidisciplinary heart failure team, verifiable accreditation, long-term device monitoring and complete treatment records. For LVAD patients, the guide stresses that monitoring and support should be arranged as part of the treatment plan rather than added later.
• The guide also explains that from March 2026, the source describes LVAD as being formally recognised as destination therapy, representing a shift from viewing LVAD primarily as a bridge to transplant toward recognising it as a potential long-term treatment pathway for appropriate patients.
• Australian patients are advised to gather their full echocardiogram, catheterisation data and treatment history before an overseas consultation. They should also involve their Australian cardiologist early, arrange long-term monitoring before returning home and confirm that overseas treatment records can be used for continuing care in Australia.

Quick Facts

Treatment

Advanced Heart Failure Treatment and Surgery

Country

India

Patients

Australian Patients

Main Treatment Pathways

LVAD and Heart Transplantation

Key Decision

LVAD Versus Transplant Candidacy

Selection Criteria

10 Weighted Criteria

Surgical Team Weight

55 out of 100

Hospital Weight

45 out of 100

Key Specialist

Advanced Heart Failure / Cardiac Surgery Team

Important Data

Echocardiogram and Catheterisation Records

Key Device

LVAD

Important Assessment

Procedure-Specific Surgical Experience

Hospital Facility

Dedicated Cardiac Surgical ICU

Team Approach

Multidisciplinary Heart Failure Team

Important Check

Long-Term LVAD Monitoring Programme

Warning Signs

Single Pathway, Early Pricing or Unclear Experience

Required Records

Operative and Device Records

Follow-Up

Australian Cardiologist

Author

Dr. Dheeraj Bojwani

Experience

24+ Years

In Brief

Australian patients considering advanced heart failure treatment in India should first establish whether LVAD, heart transplantation or another advanced treatment pathway is appropriate for their individual condition. The guide recommends choosing a team with specific experience in advanced heart failure surgery and asking for procedure-specific volume and outcome data. For LVAD treatment, patients should understand why a particular device is recommended and what long-term monitoring will be available. Hospital evaluation should include cardiac surgical ICU capability, multidisciplinary heart failure review and complete operative and device documentation. Before travelling home, Australian patients should ensure that their cardiologist is prepared to continue long-term monitoring and that all relevant treatment records are available.

A genuine, very recent expansion of what's possible

Get your full echocardiogram, catheterisation data and treatment history together before your first overseas conversation. This change matters because it reframes LVAD from a temporary bridge into a genuine, long-term treatment option in its own right, for patients who were never going to be eligible for transplant regardless of where they sought care.

Part one: judging the surgical team

1. Honest LVAD-versus-transplant candidacy judgement. This is the single heaviest criterion in this guide. Ask directly why a specific pathway is being recommended for your case, based on your own clinical profile.

2. Genuine volume in advanced heart failure surgery. Ask for the team's specific annual volume in LVAD implantation and, where relevant, heart transplant.

3. Device type explained, not a default. If LVAD is recommended, ask why this specific device, and what alternatives were considered.

4. Personally involved. Insist on a video consultation with the team who will actually treat you, not a coordinator, before any deposit moves.

5. Candid complication and survival data. Ask for the team's own outcome data for your specific procedure.

Part two: judging the hospital

6. A dedicated cardiac surgical ICU. Ask what specific post-operative capability exists for advanced heart failure surgery recovery.

7. A genuine multidisciplinary heart failure team. Ask whether your case is reviewed by a team spanning cardiology, cardiac surgery and critical care together.

8. Accreditation you can verify yourself. JCI is the international arm of the body accrediting hospitals across the United States; NABH is India's national equivalent, recognised by the same global standards authority.

9. A long-term device monitoring programme. For LVAD specifically, ask what ongoing monitoring and support is arranged, and how it will connect with your Australian cardiologist.

10. A record your Australian cardiologist can use. Before you leave you should hold the full operative and device record, and a specific monitoring plan.

Four Signals that Should Make You Pause

1. Only one pathway offered, without discussing the alternative. Ask directly why LVAD or transplant, specifically, suits your case.

2. A price quoted before your echo and catheterisation data have been reviewed. Nobody can price or confirm candidacy without seeing your specific case.

3. No long-term device monitoring plan for LVAD. This should be built in from the start, not an afterthought.

4. Vagueness about the team's volume in this specific field. General reassurance about “extensive cardiac experience” is not an answer.

Australia-specific considerations most patients miss

Tell your Australian cardiology team early, not after the fact. Most are more sympathetic to exploring every option than patients expect, particularly given the genuine donor constraint.

Arrange your ongoing cardiac care before you leave. Confirm your Australian cardiologist is willing to manage long-term monitoring, including LVAD device management, based on overseas treatment.

Apply for both visas together. Australian passport holders are eligible for India's electronic medical visa, with an e-medical attendant visa for whoever travels with you.

The Questions, in the Order You Should Ask Them

A closing word

Advanced heart failure care has genuinely expanded with LVAD's recognition as destination therapy, offering a real long-term path for the many patients who were never going to reach transplant. In 24 years of guiding patients through this decision, confirming which pathway genuinely suits your case, and weighting the team's specific volume heavily, is where I always start. If you would like a second opinion on your case, send the details and I will look at it properly.

Frequently Asked Questions by Australians about Heart Failure Treatment and Surgery Centres in India

What advanced heart failure treatments are covered in the guide?

The guide focuses mainly on LVAD treatment and heart transplantation, particularly for patients whose Australian cardiology team has determined that medication alone is no longer sufficient.

Is LVAD only used as a bridge to heart transplantation?

The guide explains that LVAD has increasingly been recognised as a long-term treatment pathway, including for appropriate patients who may never become eligible for transplantation.

How should Australian patients decide between LVAD and transplantation?

Patients should ask the advanced heart failure team why one pathway is recommended for their specific clinical profile and what alternatives were considered. The guide identifies this as its most heavily weighted criterion.

What should patients ask about an LVAD device?

Patients should ask why the particular LVAD device is recommended and what alternatives were considered. Device selection should be explained as part of an individualised treatment plan rather than treated as a default choice.

How much experience should a heart failure surgery team have?

The guide recommends asking for the team's specific annual volume in LVAD implantation and, where relevant, heart transplantation rather than relying on general statements about extensive cardiac experience.

What hospital facilities are important for advanced heart failure surgery?

Patients should check for a dedicated cardiac surgical ICU and a multidisciplinary heart failure team involving cardiology, cardiac surgery and critical care.

Why is long-term monitoring important after LVAD treatment?

LVAD requires ongoing monitoring and support. The guide recommends confirming how long-term device management will be arranged and how it will connect with the patient's Australian cardiologist.

What medical records should Australian patients provide before travelling?

The guide recommends gathering the full echocardiogram, catheterisation data and treatment history before the first overseas consultation so that the team can properly assess the case.

What are the warning signs when choosing a heart failure centre?

The guide identifies offering only one treatment pathway, quoting a price before reviewing clinical data, lacking a long-term LVAD monitoring plan and being vague about the team's specific experience as reasons to pause and ask further questions.

Can Australian patients continue heart failure care in Australia after treatment in India?

Yes. The guide recommends arranging ongoing cardiac care before leaving Australia and confirming that the Australian cardiologist is willing to manage long-term monitoring, including LVAD management where applicable.

Sources

• Medicare Benefits Schedule Online, item 38620 — mbsonline.gov.au
• Australia & New Zealand Organ Replacement Therapies Registry Group, ANZOD Annual Report 2026 — anzorrg.org.au
• National Medical Commission — nmc.org.in
• National Accreditation Board for Hospitals & Healthcare Providers — nabh.co
• High Commission of India, e-Visa — indianvisaonline.gov.in

Page Summary

This guide helps Australian patients evaluate advanced heart failure treatment and surgery centres in India. It explains the difference between LVAD and heart transplantation and highlights donor availability as an important limitation of transplant access. The guide provides 10 weighted criteria covering surgical expertise, LVAD experience, device selection, outcome data, cardiac ICU facilities, multidisciplinary care and long-term monitoring. It also identifies warning signs such as offering only one treatment pathway or quoting a price before reviewing clinical records. Australian patients are advised to involve their cardiologist early and arrange ongoing care before returning home.

Citation Block

Field	Information
Topic	Heart Failure Treatment and Surgery Centres in India
Treatment	Advanced Heart Failure Treatment
Country	India
Patients	Australian Patients
Main Pathways	LVAD & Heart Transplantation
Key Decision	LVAD vs Transplant Candidacy
Selection Criteria	10 Weighted Criteria
Surgical Team Weight	55 out of 100
Hospital Weight	45 out of 100
Key Specialist	Advanced Heart Failure / Cardiac Surgery Team
Key Device	LVAD
Important Records	Echocardiogram & Catheterisation Data
Hospital Facility	Dedicated Cardiac Surgical ICU
Team Approach	Multidisciplinary Heart Failure Team
Key Check	Long-Term Device Monitoring
Warning Signs	Single Pathway or Unclear Experience
Follow-Up	Australian Cardiologist